Evaluating risk, safety and efficacy of novel reproductive techniques and therapies through the EuroGTP II risk assessment tool
19.10.2020 23:35
Evaluating risk, safety and efficacy of novel reproductive techniques and therapies through the EuroGTP II risk assessment tool
Collaborators, Affiliations
- PMID: 32728714
- DOI: 10.1093/humrep/deaa146
Abstract
Study question: Can risks associated with novelties in assisted reproduction technologies (ARTs) be assessed in a systematic and structured way?
Summary answer: An ART-specific risk assessment tool has been developed to assess the risks associated with the development of novelties in ART (EuroGTP II-ART).